Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 6, 1999, Pages 1079-1099

  Stein, Dan J ^a   Van Heerden, Barend ^a   Wessels, Charmaine J ^a   Van Kradenburg, Jeanine ^a   Warwick, James ^a   Wasserman, Herman J ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

5 HT(1D) autoreceptor; Corticostriatal circuits; Obsessive compulsive disorder; Selective serotonin reuptake inhibitor; Single photon emission computed tomography

Indexed keywords

AUTORECEPTOR; CITALOPRAM; FLUOXETINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OBSESSION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECEPTOR INTRINSIC ACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; ALGORITHMS; AUTORECEPTORS; BRAIN; BRAIN CHEMISTRY; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SUMATRIPTAN; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033180228     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00051-2     Document Type: Article

References (50)

1. Altemus, M., Swedo, S.E., Leonard, H.L., Richter, D., Rubinow, D.R., Potter, W.Z. and Rapoport, J.L. (1994) Cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch. Gen. Psychiatry 51:, 794-803.
2. Ames, D., Cummings, J.L., Wirshing, W.C., Quinn, B. and Mahler, M. (1994) Repetitive and compulsive behavior in frontal lobe degenerations. J. Neuropsychiatry Clin. Neurosci. 6:, 100-113.
3. Baer, L. (1994) Factor analysis of symptom subtypes of obsessive-compulsive disorder and their relation to personality and tic disorders. J. Clin. Psychiatry 55S:, 18-23.
4. Baer, L., Rauch, S.L., Ballantine, H.T., Jr., Martuza, R., Cosgrove, R., Cassem, E., Giriunas, I., Manzo, P.A., Dimino, C. and Jenike, M.A. (1995) Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients. Arch. Gen. Psychiatry 52:, 384-92.
5. Bastani, B., Nash, J.F., Meltzer, H.Y. (1990) Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder. Arch. Gen. Psychiatry 47:, 833-839.
6. Baxter, L.R., Schwartz, J.M., Bergman, K.S., Szuba, M.P., Guze, B.H., Mazziotta, J.C., Alazraki, A., Selin, C.E., Ferng, H.K., Munford, P. and Phelps, M.E. (1992) Caudate glucose metabolic rate changes with both drug and behavior therapy for OCD. Arch. Gen. Psychiatry 49:, 681-689.
7. Bihari, K., Pato, M.T., Hill, J.L. and Murphy, D.L. (1991) Neurological soft signs in obsessive-compulsive disorder. Arch. Gen. Psychiatry 48:, 278.
8. Breiter, H.C., Rauch, S.L., Kwong, K.K., Baker, J.R., Weisskoff, R.M., Kennedy, D.N., Kendrick, A.D., Davis, T.L., Jiang, A., Cohen, M.S., Stern, C.E., Belliveau, J.W., Baer, L., O'Sullivan, R.L., Savage, C.R., Jenike, M.A. and Rosen, B.R. (1996) Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch. Gen. Psychiatry 53:, 595-606.
9. Charney, D.S., Goodman, W.K., Price, L.H., Woods, S.W., Rasmussen, S.A. and Heninger, G.R. (1988) Serotonin function in obsessive-compulsive disorder. Arch. Gen. Psychiatry 45:, 177-185.
10. Christensen, H., Hadzi-Pavlovic, D., Andrews, G. and Mattick, R. (1987) Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: A quantitative review. J. Consult Clin. Psychol. 55:, 701-711.
11. Cummings, J.L. and Cunningham, K. (1992) Obsessive-compulsive disorder in Huntington's disease. Biol. Psychiatry 31:, 263-270.
12. El Mansari, M., Bouchard, C., Blier, P. (1995) Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharm. 13:, 117-127.
13. Esman, A.H. (1989) Psychoanalysis and general psychiatry: Obsessive-compulsive disorder as paradigm. J. Am. Psychoanal. Assoc. 37:, 319-336.
14. Ferrari, M.D., Saxena, P.R. (1993) Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol. Sci. 14:, 129-133.
15. First, M.B., Spitzer, R.L., Gibbon, M. and Williams J.B. (1994) Structured Clinical Interview for Axis I DSM-IV Disorders. Biometrics Research Department, New York State Psychiatric Institute.
16. Fogelson, D.L. and Bystritsky, A. (1991) Imipramine in the treatment of obsessive-compulsive disorder with and without major depression. Ann. Clin. Psychiatry 3:, 233-237.
17. Goodman, W.K., Price, L.H., Rasmussen, S.A., Mazure, C., Fleischmann, R.L., Hill, C.L., Heninger, G.R., Charney, D.S. (1989) The yale-brown obsessive compulsive scale. I. Development, use, and reliability. Arch. Gen. Psychiatry 46:, 1006-1011.
18. Goodman, W.K., McDougle, C.J., Price, L.H., Riddle, M.A., Pauls, D.L. and Leckman, J.F. (1990) Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive compulsive disorder? J. Clin. Psychiatry S51:, 36-43.
19. Goodman, W.K., McDougle CJ, Price LH, Barr, L.C., Hills, O.F., Caplik, J.F., Charney, D.S. and Heninger, G.R. (1995) m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: Absence of symptom exacerbation. Biol. Psychiatry 38:, 138-149.
20. Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J., and Serlin, R.C. (1995) Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Arch. Gen. Psychiatry 52:, 53-60.
21. Harris, G.J., Hoehn-Saric, R., Lewis, R., Pearlson, G.D. and Streeter, C. (1994) Mapping of SPECT regional cerebral perfusion abnormalities in obsessive-compulsive disorder. Human Brain Mapping, 237-248.
22. Hollander, E., Schiffman, E., Cohen, B., Rivera-Stein, M.A.; Rosen, W., Gorman, J.M., Fyer, A.J., Papp, L. and Liebowitz, M.R. (1990) Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch. Gen. Psychiatry 47:, 27-32.
23. Hollander, E., DeCaria, C., Nitescu, A., Gully, R., Suckow, R.F., Cooper, T.B., Gorman, J.M., Klein, D.F. and Liebowitz, M.R. (1992) Serotonergic function in obsessive compulsive disorder: Behavioral and neuroendocrine responses to oral m-CPP and fenfluramine in patients and healthy volunteers. Arch. Gen. Psychiatry 49:, 21-28.
24. Hollander, E. , DeCaria, C., Gully, R., Nitescu, A., Suckow, R.F., Gorman, J.M., Klein, D.F. and Liebowitz, M.R. (1991) Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res. 36:, 1-17.
25. Hollander, E. , Stein, D.J., DeCaria, C.M., Saoud, J.B., Klein, D.F. and Liebowitz, M.R. (1993) A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biol. Psychiatry 33:, 747-749.
26. Hollander, E., Prohovnik, I. and Stein, D.J. (1995) Obsessions and cerebral blood flow during pharmacological challenge with m-CPP. J. Neuropsych. Clin. Neurosci. 7:, 485-490.
27. Insel, T.R. (1992) Toward a neuroanatomy of obsessive-compulsive disorder. Arch. Gen. Psychiatry 49:, 739-744.
28. Jenike, M.A., Breiter, H.C., Baer, L., Kennedy, D.N., Savage, C.R., Olivares, M.J., O'Sullivan, R.L., Shera, D.M., Rauch, S.L., Keuthen, N., Rosen, B.R., Caviness, V.S. and Filipek, P.A. (1996) Cerebral structural abnormalities in obsessive-compulsive disorder: A quantitative morphometric magnetic resonance imaging study. Arch. Gen. Psychiatry 53:, 625-632.
29. Karno, M., Golding, J.M., Sorenson, S.B. and Burnam, M.A. (1988) The epidemiology of obsessive-compulsive disorder in five US communities. Arch. Gen. Psychiatry 45:, 1094-1099.
30. Khanna, S. (1988) Obsessive-compulsive disorder: Is there a frontal lobe dysfunction? Biol. Psychiatry 24:, 602-613.
31. Leonard, H.L., Swedo, S.E., Rapoport, J.L., Koby, E.V., Lenane, M.C., Cheslow, D.L. and Hamburger, S.D. (1989) Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents: A double-blind crossover comparison. Arch. Gen. Psychiatry 46:, 1088-1092.
32. Loi, V., Lai, M., Pisano, M.R., and Del Zompo, M. (1996): Sumatriptan and panic-like symptoms. Am. J. Psychiatry 153:, 1505.
33. Luxenberg, J., Swedo, S., Flament, M., Friedland, R.P., Rapoport, J. and Rapoport, S.I. (1988) Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am. J. Psychiatry 145:, 1089-1093.
34. Peroutka, S.J. (1993) 5-Hydroxytryptamine receptor subtypes and the pharmacology of migraine. Neurology 43:, S34-S38.
35. Pigott, T.A., Hill, J.L., Grady, T.A., L'Heureux, F., Bernstein, S., Rubenstein, C.S., Murphy, D.L. (1992) A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to iv mcpp. Biol. Psychiatry 33:, 3-14.
36. Rauch, S.L., Jenike, M.A., Alpert, N.M., Baer, L., Breiter, H.C., Savage, C.R., Fischman, A.J. (1994) Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry 51:, 62-70.
37. Robinson, D., Wu, H., Munne, R.A., Ashtari, M. , Alvir, J.M., Lerner, G., Koreen, A., Cole, K., Bogerts, B. (1995) Reduced caudate nucleus volume in obsessive-compulsive disorder. Arch. Gen. Psychiatry 52:, 393-398.
38. Stein, D.J. (1996) Preface. In: Essential Papers on Obsessive-Compulsive Disorders, Stein, D.J., Stone, M.H. (Eds.), New York University Press, New York.
39. Stein, D.J., Hollander, E., Chan, S., DeCaria, C.M., Hilal, S. and Liebowitz, M.R. (1993): Computerized tomography and soft signs in obsessive-compulsive disorder. Psychiatry Res. 50:, 143-150.
40. Stein, D.J., Spadaccini, E. and Hollander, E. (1995) Meta-analysis of pharmacotherapy trials for obsessive compulsive disorder. Int. Clin. Psychopharm. 10;, 11-18.
41. Stein, D.J., Maud, C.M., Bouwer, C. (1996) Use of the serotonin selective reuptake inhibitor citalopram in obsessive-compulsive disorder. J. Serotonin Research 1:, 29-33.
42. 1D receptors in the pathophysiology and treatment of obsessive-compulsive disorder. CNS Spectrums 3:, 46-49.
43. Swedo, S.E., Rapoport, J.L., Cheslow, D.L., Leonard, H.L., Ayoub, E.M., Hosier, D.M. and Wald E.R. (1989) High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. Am. J. Psychiatry 146:, 246-249.
44. Swedo, S.E., Pietrini, P., Leonard, H.L., Schapiro, M.B., Rettew, D.C., Goldberger, E.L, Rapoport, S.I., Rapoport, J.L. and Grady, C.L. (1992) Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: Revisualization during pharmacotherapy. Arch. Gen. Psychiatry 49:, 690-694.
45. Weissman, M.M., Bland, R.C., Canino, G.J., Greenwald, S., Hwu, H.G., Lee, C.K., Newman, S.C., Oakley-Browne, M.A. , Rubio-Stipec, M., Wickramaratne, P.J., Wittchen, H-U. and Yeh, E-K. (1994): The cross national epidemiology of obsessive compulsive disorder. J. Clin. Psychiatry 55S:, 5-10.
46. Wise, S.P. and Rapoport, J.L. (1989) Obsessive-compulsive disorder: Is it basal ganglia dysfunction? In: Obsessive-Compulsive Disorders in Children and Adolescents, Rapoport J.L. (Ed), American Psychiatric Press, Washington, DC.
47. Zohar, J. (1993) Pharmacological challenges in OCD. Presented at the International Obsessive-Compulsive Disorder Conference, Capri, Italy.
48. Zohar, J. and Insel, T.R. (1987) Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment, and pathophysiology. Biol. Psychiatry 22:, 667-687.
49. Zohar, J., Mueller, E.A., Insel TR, Zohar-Kadouch, R.C., Murphy, D.L. (1987): Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls. Arch. Gen. Psychiatry 44:, 946-951.
50. Zohar, J., Insel, T.R., Zohar-Kadouch, R.C., Hill, J.L. and Murphy, D.L. (1988) Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Arch. Gen. Psychiatry 45:, 167-172.